Morgan Stanley reports 5.3% stake in Aramark

Aramark reported institutional ownership disclosure by Morgan Stanley reporting units.

Rhea-AI Filing Summary

Aramark reported institutional ownership disclosure by Morgan Stanley reporting units. The Schedule 13G/A shows 13,801,394 shares beneficially owned, representing 5.3% of the class as of 03/31/2026. The filing attributes voting and dispositive powers to shared MS reporting units.

Insights

Institutional Ownership Analyst

Morgan Stanley reports a 5.3% passive stake in Aramark via reporting units.

The filing lists 13,801,394 shares beneficially owned as of 03/31/2026, with shared voting power of 12,736,515 and shared dispositive power of 13,322,760. The disclosure follows the Release No. 34-39538 aggregation approach for MS reporting units.

This is a routine passive ownership disclosure under Schedule 13G/A. Future filings may update percentages or holdings; any change in voting or disposition authority would be disclosed in subsequent amendments.

Key Figures

Beneficially owned shares: 13,801,394 shares Percent of class: 5.3% Shared voting power: 12,736,515 shares +2 more

5 metrics

Beneficially owned shares 13,801,394 shares Amount beneficially owned as of 03/31/2026

Percent of class 5.3% Percent of common stock represented by holdings as of 03/31/2026

Shared voting power 12,736,515 shares Shared power to vote reported on cover page

Shared dispositive power 13,322,760 shares Shared power to dispose reported on cover page

Aggregation release cited Release No. 34-39538 Aggregation approach for MS reporting units per filing

Key Terms

Schedule 13G/A, Beneficially owned, Shared dispositive power, Release No. 34-39538

4 terms

Schedule 13G/A regulatory

"The Schedule 13G/A shows 13,801,394 shares beneficially owned"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned financial

"Amount beneficially owned: See the response(s) to Item 9"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Shared dispositive power financial

"Shared Dispositive Power 13,322,760.00"

Release No. 34-39538 regulatory

"In Accordance with the Release No. 34-39538 (January 12, 1998)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Morgan Stanley report in ARMK?

Morgan Stanley's reporting units state beneficial ownership of 13,801,394 shares, equal to 5.3% of Aramark's common stock as of 03/31/2026. The figures are reported on a Schedule 13G/A and reflect aggregated MS reporting units per the filing.

What voting and dispositive powers are reported by Morgan Stanley for ARMK?

The filing shows shared voting power of 12,736,515 shares and shared dispositive power of 13,322,760 shares. The filing lists no sole voting or sole dispositive power amounts for the reporting units.

Does this Schedule 13G/A indicate active control or intent to influence Aramark?

This Schedule 13G/A reports passive institutional ownership under the aggregation rules; it does not state any intent to influence or control. The filing follows the specified aggregation approach in Release No. 34-39538 for MS reporting units.

Which date do the ownership figures refer to in the ARMK filing?

The reported ownership figures are stated as of 03/31/2026. The Schedule 13G/A cover page and Item 9 reference this date for the beneficial ownership amounts and percentage.

Who signed the ARMK Schedule 13G/A on behalf of Morgan Stanley?

The filing is signed by Claire Gordon as an Authorized Signatory for Morgan Stanley, with the signature date recorded as 05/11/2026 in the document.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 11:42 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Aramark

(Name of Issuer)

Common Stock

(Title of Class of Securities)

03852U106

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 03852U106

1

Names of Reporting Persons

Morgan Stanley

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 12,736,515.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 13,322,760.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

13,801,394.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.3 %

12

Type of Reporting Person (See Instructions)

HC, CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Aramark
(b)	Address of issuer's principal executive offices: 2400 MARKET STREET, PHILADELPHIA, PA, 19103
Item 2.
(a)	Name of person filing: Morgan Stanley
(b)	Address or principal business office or, if none, residence: 1585 Broadway, New York, NY 10036
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 03852U106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: 5.3 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Morgan Stanley

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley
Date:	05/11/2026